🇮🇳 *India Daybook*

🔹 *Stocks to watch for*

Sun Pharma gets USFDA nod for aspirin capsules (Positive)

Tamilnadu Petro: CARE upgraded rating for Long/Short term Bank facilities with stable outlook (Positive)

Jubilant: IND-Ra has upgraded the Company's Long Term credit rating to 'IND AA/Stable (Positive)

Britannia Industries’ board approves stock split of one share to two shares. (Positive)

Reliance Industries to load 80,000 tonne of vacuum gas oil at Sikka (Positive)

TVS Motor Company strengthened its commuter motorcycle portfolio with the launch of TVS Radeon (Positive)

Aban Offshore’s board seeks shareholder’s approval to raise $400 million from foreign markets (Positive)

Goa Carbon: Ajo Emerging Markets Small-Cap Master Fund Ltd. acquired 50,000 shares (Positive)

Liberty Shoes: India Nivesh Limited acquired 1.3 lakh shares, or 0.76 percent at Rs 217.55 each (Positive)

Tata Investment: 1Q net income 224.8m rupees vs 179.8m a year ago (Positive)

Adani Wilmar's bid for Ruchi Soya approved with over 96% approval from Committee of Creditors. (Positive)

Punjab National Bank likely to take a call on debt resolution for some stressed assets today (Positive)

IndiGo said that some of its Airbus A320 Neo aircrafts had been grounded “proactively” due to “non-availability” of spare engines from the manufacturer. (Negative)

Hexaware Technologies promoters look to raise Rs 1,120 crore via qualified institutional placement at floor price of Rs 447.5 per share (Negative)

Monnet Ispat: Says exchange informed trading in shares will be suspended from Aug. 29 (Negative)

GST collections could slow down in July, sources say the mop-up could be around Rs 90,000 cr (Negative)

Citi on Eris Lifesciences: Maintained ‘Buy’ with a price target of Rs 850. ERIS believes that the Indian market has a long growth runway. (Positive)

Apollo Hospitals' recovery delayed but not derailed, says Nomura. Maintained ‘Buy’ with a price target of Rs 1340 (Positive)

With stable asset quality, ICICI Bank stock's valuation can re-rate, CLSA believes. Target price Rs 430 (Positive)

UBS on ONGC: Maintained ‘Buy’ with a price target of Rs 245. Deleveraging through potential listing of OVL and non-core asset sales. (Positive)

CLSA on M&M: Maintained ‘Buy’ with a price target of Rs 1,120. Success of new MPV and SUV could boost growth and lift valuations. (Positive)

JPMorgan on L&T: Maintained ‘Overweight’ with a price target of Rs 1,600. If everyone participate in buyback, then ratio would be 4.29:100 for tendering shares. (Positive)

Credit Suisse on Indian Steel: Stabilizing raw material costs drive steel price rebound. Indian steel price to rebound with rising China domestic prices and export. (Positive)

JPMorgan on Indian Steel: Prices could move higher post October on China and domestic environment. Strong pricing environment creates upside risks for TATA, JSW and SAIL. (Positive)

Citi on Sun Pharma: Maintained ‘Neutral’ with a price target of Rs 600. Positive CHMP opinion for Tildrakizumab has played out. (Neutral)

Macquarie on Bandhan Bank: Company may see several integration risks if bid for PNB Housing, Target Rs 561 (Negative)